<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
Last Updated: May 29, 2026 03:25:27 PM (GMT)
ALKS: The current market price is 42.315, reflecting a percentage change of +5.29% from the previous price.
Support and Resistance Levels The current support levels are 40.27667, 39.14333, and 38.35667, while the resistance levels are 42.19667, 42.98333, and 44.11667. The pivot point is at 41.06333.
Indicators RSI is currently at 74.6, with a downward trend noted in the history. The ATR is at 0.45422, and the Parabolic SAR indicates bullish momentum at 38.80375. The MACD shows a bearish histogram of -0.06891. The 50-day SMA is at 39.12995, above the 200-day EMA of 38.10772.
Market Sentiment Given the price is above the pivot point (41.06333) and with bullish indicators, a bullish scenario is predicted.
ALKS Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (ALKS) Alkermes plc
Company Background
Alkermes plc (NASDAQ: ALKS) is a biopharmaceutical company based in the United States, dedicated to the development and commercialization of innovative therapies for patients with serious mental health and neurological disorders. Founded in 2010, Alkermes has established itself as a leader in the field of central nervous system (CNS) therapeutics, focusing on areas such as schizophrenia, depression, addiction, and multiple sclerosis. The company leverages advanced science and robust clinical development capabilities to create transformational treatments that improve patient outcomes and quality of life.
Market Position
Alkermes operates within a competitive market landscape, characterized by rapid advancements in drug development and increasing demand for effective mental health therapies. The company is well-positioned as a key player in the biopharmaceutical industry, with a strong portfolio of marketed products, including ARISTADA, a long-acting injectable treatment for schizophrenia, and VIVITROL, an injectable medication for opioid and alcohol dependence. Alkermes’ commitment to research and innovation ensures that it remains at the forefront of addressing unmet medical needs, making it a trusted partner among healthcare providers.
Key Financial Highlights
Alkermes has demonstrated robust financial performance, with consistent revenue growth driven by its commercially successful products and a diverse pipeline of investigational therapies. As of the most recent fiscal year, the company recorded significant year-over-year revenue increases, underpinned by strong demand for its key products. Alkermes is strategically investing in R&D to expand its product portfolio and pipeline, focusing on next-generation therapies and novel drug delivery systems. The company’s emphasis on operational efficiency and cost management has further solidified its financial stability, making it an attractive stock option for investors seeking exposure to the biopharmaceutical sector.
Industry Highlights
The biopharmaceutical industry continues to evolve, with increasing emphasis on personalized medicine and innovative treatment approaches. Alkermes is well-positioned to capitalize on these trends, leveraging its expertise in CNS drug development to meet the growing demand for effective and accessible mental health therapies. The company's strong clinical pipeline and commitment to addressing pressing healthcare challenges make it a noteworthy player in the biopharmaceutical landscape, poised for continued growth and success.
How to Buy or Trade Alkermes plc Stock (ALKS) with AvaTrade
Trading or investing in Alkermes plc stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol ALKS, which represents Alkermes plc. Before placing a trade, review the live Alkermes plc share price, market trend, spread, leverage options, and recent market news that could impact the stock price.
The next step is deciding whether you want to buy or sell Alkermes plc stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Alkermes plc earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.
Related Stocks
Sidebar rates
- <% signal.pair %>
<% signals.active.Current.rate.substr(0,7) %>
